Melinda is a global biopharmaceutical and digital health leader with a mix of commercial and R&D expertise. She has a strong background in digital therapeutics, digital medicines and digital marketing, across broad therapeutic areas and markets. She currently serves as an advisor to several companies focused on digital health, as well as to MIT’s Health Science and Technology program. She previously held leadership roles at both AstraZeneca and Pfizer, and most recently was the Chief Commercial Officer at Mymee, a leading digital health company focused in autoimmune disease. Melinda holds an MS in Biochemical Engineering and an MBA in Finance and Marketing.